首页> 外国专利> COMPOSITIONS ON THE BASIS OF IRNA FOR FACTOR XII (HAGEMAN FACTOR) (F12), PLASMA KALLIKREIN B (FLETCH FACTOR) 1 (KLKB1) AND KININOGEN 1 (KNG1) AND FOSTER OF THE FLETCHER) (1)

COMPOSITIONS ON THE BASIS OF IRNA FOR FACTOR XII (HAGEMAN FACTOR) (F12), PLASMA KALLIKREIN B (FLETCH FACTOR) 1 (KLKB1) AND KININOGEN 1 (KNG1) AND FOSTER OF THE FLETCHER) (1)

机译:因子XII(Hageman因子)(F12),血浆激肽释放酶B(Fletch因子)1(KLKB1)和激肽原1(KNG1)以及Foster的寄主的IRNA组成

摘要

The present invention relates to agents for RNAi, for example, double-stranded agents for RNAi specifically targeting the plasma kallikrein B gene (Fletcher factor) 1 (KLKB1), the factor XII gene (Hagemann factor (F12) or the kininogen 1 gene (KNG1), and methods of using such agents for RNAi to inhibit the expression of the KLKB1 gene, the F12 gene and / or the KNG1 gene, and to methods of treating subjects with hereditary angioedema (HAE) and / or a disorder associated with contact by activating blood coagulation.
机译:本发明涉及RNAi的试剂,例如,特异性靶向血浆激肽释放酶B基因(弗莱彻因子)1(KLKB1),因子XII基因(哈格曼因子(F12)或激肽原1基因(RNA)的RNAi双链试剂。 (KNG1),以及使用此类试剂用于RNAi抑制KLKB1基因,F12基因和/或KNG1基因表达的方法,以及治疗患有遗传性血管性水肿(HAE)和/或与接触有关的疾病的受试者的方法通过激活血液凝固。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号